Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $23.0M | $25.9M | $28.3M | $31.3M | $32.5M | $35.8M | $41.7M | $48.1M | $54.7M | $64.0M |
| Revenue growth | — | 12.5% | 9.5% | 10.6% | 3.7% | 10.1% | 16.5% | 15.4% | 13.8% | 17.0% |
| Gross profit | $17.9M | $20.6M | $21.8M | $23.8M | $25.2M | $27.3M | $31.4M | $36.5M | $41.7M | $50.0M |
| Gross margin | 77.7% | 79.5% | 76.9% | 76.2% | 77.6% | 76.4% | 75.5% | 76.0% | 76.3% | 78.1% |
| Operating income | $3.11M | $3.57M | $2.71M | $2.83M | $5.12M | $3.14M | $2.97M | $4.01M | $6.58M | $9.66M |
| Operating margin | 13.5% | 13.8% | 9.6% | 9.0% | 15.8% | 8.8% | 7.1% | 8.3% | 12.0% | 15.1% |
| Net income | $2.21M | $2.23M | $1.83M | $1.98M | $4.16M | $2.36M | $2.31M | $3.17M | $5.15M | $7.54M |
| Net margin | 9.6% | 8.6% | 6.5% | 6.3% | 12.8% | 6.6% | 5.5% | 6.6% | 9.4% | 11.8% |
| EPS (diluted) | $0.27 | $0.26 | $0.21 | $0.23 | $0.47 | $0.27 | $0.26 | $0.36 | $0.58 | $0.85 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.17M | $1.19M | $2.44M | $2.59M | $4.20M | $3.08M | -$686K | $1.31M | $9.07M | $11.4M |
| Capital expenditures | $535K | $619K | $526K | $1.33M | $844K | $287K | $1.43M | $1.65M | $287K | $262K |
| Free cash flow | $1.63M | $572K | $1.92M | $1.26M | $3.35M | $2.79M | -$2.11M | -$333K | $8.78M | $11.1M |
| Share buybacks | — | — | — | — | — | $1.12M | $1.45M | $153K | $275K | $10.0M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | $10.5M | $11.9M | $8.15M | $7.37M | $16.1M | $15.3M |
| Total assets | $20.6M | $23.1M | $27.4M | $29.4M | $33.2M | $37.1M | $41.4M | $45.8M | $52.2M | $53.8M |
| Total liabilities | $4.22M | $3.99M | $4.74M | $3.67M | $3.00M | $4.69M | $7.19M | $8.14M | $7.69M | $10.6M |
| Long-term debt | $1.15M | $1.10M | — | — | — | — | — | — | — | — |
| Shareholders' equity | $16.4M | $19.8M | $22.6M | $25.7M | $30.3M | $32.4M | $34.2M | $37.7M | $44.5M | $43.2M |
| Retained earnings | $2.73M | $4.96M | $7.55M | $9.52M | $13.7M | $14.9M | $15.8M | $18.8M | $23.7M | $21.2M |
| Shares (wtd avg diluted) | 8.25M | 8.46M | 8.62M | 8.63M | 8.83M | 8.91M | 8.77M | 8.70M | 8.86M | 8.91M |
Every figure is extracted from Electromed, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.